CORC

在结果中检索

CORC

浏览/检索结果: 共106条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Fan, Ying;  Qin, Jing;  Han, Na;  Lu, Hongyang
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun
收藏  |  浏览/下载：21/0  |  提交时间：2020/10/26
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
LUNG CANCER, 2019, 卷号: 127
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 84-89
作者:  Xiaohua Gu;  Qiang Zhang;  Yun-Bo Chu;  Yi-Yang Zhao;  Yan-Jun Zhang
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/13
Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China 期刊论文
Clinical Therapeutics, 2019
作者:  Xiaoyou Li;  Muhammad Abbas;  Yun Li;  Yue Teng;  Ying Fang
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/17
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
LUNG CANCER, 2019, 卷号: Vol.127, 页码: 84-89
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/17
Pemetrexed exerts anticancer effects by inducing G(0)/G(1)-phase cell cycle arrest and activating the NOXA/Mcl-1 axis in human esophageal squamous cell carcinoma cells 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 2, 页码: 1851-1858
作者:  Li, Xinying;  Song, Hongxia;  Kong, Feng;  Guo, Yanxia;  Chen, Yuan
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. 期刊论文
Lung cancer (Amsterdam, Netherlands), 2019, 卷号: Vol.127, 页码: 84-89
作者:  Xiaohua Gu;  Qiang Zhang;  Yun-Bo Chu;  Yi-Yang Zhao;  Yan-Jun Zhang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/13
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. 期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 84-89
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17
Randomized controlled trial of endostar combined with cisplatin/pemetrexed chemotherapy for elderly patients with advanced malignant pleural effusion of lung adenocarcinoma 期刊论文
JOURNAL OF BUON, 2018, 卷号: 23, 期号: 1
作者:  Wang, Xiao Jie;  Miao, Kun;  Luo, Yan;  Li, Rui;  Shou, Tao
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/04

©版权所有 ©2017 CSpace - Powered by CSpace